Trehalose derivatives and pharmaceutical compositions for treating neurodegenerative diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9371350
APP PUB NO 20150025035A1
SERIAL NO

14509175

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invented inositol and trehalose derivatives, prepared by introducing multiple units of the guanidine group to the backbone molecules, show excellent blood-brain barrier permeability, and accordingly, it can be easily transported to the brain tissues and utilized for the treatment of neurodegenerative diseases such as Alzheimer's disease and Huntington's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POSTECH FOUNDATIONPOHANG-CITY KYUNGSANGBUK-DO 790-784

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chung, Sung-Kee Pohang-si, KR 9 21
Ghosh, Subhash C Pohang-si, KR 2 9
Im, Jungkyun Seoul, KR 7 27
Kim, Boram Gwangju-si, KR 43 275
Lee, Woo Sirl Guri-si, KR 10 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 21, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00